Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2002]-
    • Subject Terms:
      Drug Resistance, Bacterial*; Anti-Bacterial Agents/*pharmacology ; Campylobacter coli/*drug effects ; Campylobacter coli/*physiology ; Campylobacter jejuni/*drug effects ; Campylobacter jejuni/*physiology ; Membrane Transport Proteins/*physiology; Bacterial Proteins/physiology ; Ciprofloxacin/pharmacology ; DNA, Bacterial ; Diarrhea/microbiology ; Feces/microbiology ; Humans ; Microbial Sensitivity Tests ; Random Amplified Polymorphic DNA Technique ; Tetracycline/pharmacology
    • Abstract:
      Background: Campylobacter resistance to antimicrobial agents is regarded as a major concern worldwide. The aim of this study was to investigate the expression of the CmeABC efflux pump and the RAPD-PCR pattern in drug-resistant Campylobacter isolates.
      Methods: A total of 283 stool specimens were collected from children under the age of five with diarrhea. The minimum inhibitory concentration (MIC) of tetracycline and ciprofloxacin was determined by broth microdilution method and E-test, respectively. Detection of tetracycline and ciprofloxacin determinants was done by amplification of tetO gene and PCR-sequencing of the gyrA gene. The cmeABC transcriptional expression was analyzed by Real-time (RT)-PCR. Clonal correlation of resistant strains was determined by RAPD-PCR genotyping.
      Results: Out of 283 fecal samples, 20 (7.02%) samples were positive for Campylobacter spp. Analysis of duplex PCR assay of the cadF gene showed that 737 and 461 bp amplicons were corresponding to Campylobacter jejuni and Campylobacter coli, respectively. All of the 17 phenotypically tetracycline-resistant Campylobacter isolates harbored the tetO gene. Also, four phenotypically ciprofloxacin-resistant Campylobacter isolates had a point mutation at codon 257 of the gyrA gene (ACA to ATA; Thr > Ile). High-level expression of the cmeA gene was observed in ciprofloxacin-resistant and high-level tetracycline-resistant Campylobacter isolates, suggesting a positive correlation between the cmeA gene expression level and tetracycline resistance level. Moreover, a statistically significant difference was observed in the cmeA gene expression between ciprofloxacin-resistant and ciprofloxacin-susceptible strains, which signifies the crucial contribution of the efflux pump in conferring multiple drug resistance phenotype among Campylobacter spp. RAPD analysis of Campylobacter isolates exhibited 16 different patterns. Simpsone`s diversity index of RAPD-PCR was calculated as 0.85, showing a high level of homogeneity among the population; however, no clear correlation was detected among tetracycline and/or ciprofloxacin resistant isolates.
      Conclusion: Significant contribution of the CmeABC efflux pump in conferring high-level resistance to tetracycline and ciprofloxacin was observed in C. jejuni and C. coli clinical isolates. The resistant phenotype is suggested to be mediated by CmeABC efflux pumps, the tetO gene, and point mutation of the gyrA gene. Genotyping revealed no clonal correlation among resistant strains, indicating distinct evolution of tetracycline and ciprofloxacin resistant genotypes among the isolates.
    • References:
      Poult Sci. 2010 May;89(5):1015-20. (PMID: 20371855)
      Antimicrob Agents Chemother. 2007 Mar;51(3):1123-5. (PMID: 17210776)
      Antimicrob Agents Chemother. 2003 Jan;47(1):390-4. (PMID: 12499221)
      Nat Rev Gastroenterol Hepatol. 2011 Oct 25;8(12):669-85. (PMID: 22025030)
      J Antimicrob Chemother. 2005 Sep;56(3):491-7. (PMID: 16055509)
      Antimicrob Agents Chemother. 2005 Aug;49(8):3347-54. (PMID: 16048946)
      Antimicrob Agents Chemother. 2004 Sep;48(9):3442-50. (PMID: 15328109)
      Infect Immun. 2001 Apr;69(4):2462-9. (PMID: 11254608)
      Iran Biomed J. 2016;20(2):91-6. (PMID: 26783018)
      J Prev Med Hyg. 2017 Jun;58(2):E79-E92. (PMID: 28900347)
      Lancet. 1986 Jul 19;2(8499):146-9. (PMID: 2873408)
      J Clin Microbiol. 2003 Aug;41(8):3926-8. (PMID: 12904420)
      Front Cell Infect Microbiol. 2012 Mar 01;2:21. (PMID: 22919613)
      Future Microbiol. 2009 Mar;4(2):189-200. (PMID: 19257846)
      Clin Infect Dis. 2001 Apr 15;32(8):1201-6. (PMID: 11283810)
      J Bacteriol. 2005 Nov;187(21):7417-24. (PMID: 16237025)
      Indian J Med Res. 2013 Jan;137(1):187-90. (PMID: 23481071)
      Antimicrob Agents Chemother. 1996 Jan;40(1):1-5. (PMID: 8787868)
      Int J Antimicrob Agents. 2004 May;23(5):468-72. (PMID: 15120725)
      Antimicrob Agents Chemother. 2007 Sep;51(9):3212-6. (PMID: 17606685)
      Avian Pathol. 2014;43(2):176-82. (PMID: 24689432)
      Front Microbiol. 2016 Jul 13;7:1097. (PMID: 27468281)
      Antimicrob Agents Chemother. 2002 Jul;46(7):2124-31. (PMID: 12069964)
      mBio. 2016 Sep 20;7(5):. (PMID: 27651364)
      Antimicrob Agents Chemother. 2003 Mar;47(3):1125-8. (PMID: 12604552)
      Antimicrob Agents Chemother. 2005 Jul;49(7):2753-9. (PMID: 15980346)
      BMC Microbiol. 2017 Apr 4;17(1):80. (PMID: 28376713)
      Jundishapur J Microbiol. 2016 Feb 09;9(2):e29645. (PMID: 27127589)
      Int J Antimicrob Agents. 2001 Oct;18(4):359-64. (PMID: 11691569)
      FEMS Microbiol Lett. 2007 Feb;267(1):89-94. (PMID: 17166222)
      Antimicrob Agents Chemother. 2010 Mar;54(3):1232-6. (PMID: 20038624)
      BMC Infect Dis. 2016 Nov 21;16(1):692. (PMID: 27871251)
      Nat Commun. 2017 Aug 1;8(1):171. (PMID: 28761097)
      Emerg Infect Dis. 2007 Feb;13(2):259-66. (PMID: 17479889)
      Braz J Microbiol. 2012 Apr;43(2):535-43. (PMID: 24031861)
      Am J Clin Nutr. 2000 Dec;72(6):1516-22. (PMID: 11101480)
      J Clin Microbiol. 1988 Nov;26(11):2465-6. (PMID: 3069867)
      Antimicrob Agents Chemother. 2003 Dec;47(12):3675-81. (PMID: 14638464)
      J Antimicrob Chemother. 2003 Aug;52(2):220-3. (PMID: 12865393)
      Antimicrob Agents Chemother. 1995 Sep;39(9):2019-22. (PMID: 8540709)
      Lancet. 2005 Nov 5;366(9497):1653-66. (PMID: 16271648)
      Epidemiol Infect. 2013 Dec;141(12):2526-35. (PMID: 23445833)
    • Contributed Indexing:
      Keywords: Antibiotic resistance; Campylobacter; Efflux pump; RAPD-PCR; RT-PCR
    • Accession Number:
      0 (Anti-Bacterial Agents)
      0 (Bacterial Proteins)
      0 (DNA, Bacterial)
      0 (Membrane Transport Proteins)
      5E8K9I0O4U (Ciprofloxacin)
      F8VB5M810T (Tetracycline)
    • Publication Date:
      Date Created: 20210521 Date Completed: 20211004 Latest Revision: 20211004
    • Publication Date:
      20240829
    • Accession Number:
      PMC8138983
    • Accession Number:
      10.1186/s12941-021-00439-6
    • Accession Number:
      34016127